Key players in global Health R&D: How we can address the global health needs through partnerships?
The GHIT Fund, along with the Health and Global Policy Institute (HGPI), are co-hosting a panel – comprised of key players in global health R&D – to discuss how we can address the global heath needs through cross sector partnerships.
This is an event open to the public, but you must pre-register for the program. Seating is available on a first come, first served basis. Please visit the registration on HGPI website below.
December 3rd, 2013 7:30pm−9:30pm
Academy Hills Sky Studio
6-10-1, Roppongi, Minato-ku, Tokyo, 106-6149
Roppongi Hills Mori Tower 49F
Dr. Hannah Kettler(Global health, Life science partnership, Senior Program Officer, The Bill & Melinda Gates Foundation)
Dr. Andrea Lucard (Executive Vice-president, External Relations, Medicines for Malaria Venture)
Dr. Sharon Chan (Head ASIA, AERAS)
MORI Building Co.,Ltd
■Fee： 1500yen (Students 1000yen) for each session
English (Simultaneous translation will be provided at the venue)
7:30pm-8:30pm Presentation by each panelist
8:30pm-9:30pm Pane Discussion and Q&A
Health and Global Policy Institute (HGPI）
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well being and to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund (GHIT Fund)
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies for the developing world. The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and the Bill & Melinda Gates Foundation. The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious diseases. The goals is to facilitate and fund global health R&D partnerships that can generate new drugs,vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing world (www.ghitfund.org)
Health and Global Policy Institute